PAR 6.67% 24.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3020

  1. 4,434 Posts.
    lightbulb Created with Sketch. 6997
    Incidentally Hamman, I forgot to mention, ages ago when you first posted that one of your wife's excellent observations was that of the reduction of blood pressure, where she had been on (was it one of the 'Sartans' or 'Prills'? (Eg Rampril, Irbesartan etc?)) for some 15 years!! After a course of iPPS her Doc said for the first time, you don't need to be on those any more....


    Anyway, I looked that up as I remember coming across research on Pentosan and Hypertension, sure enough, there is animal model evidence of the amazing affects of PPS on Blood Pressure and Renal pressure.


    Want more than just a general Mozz saying he remembers something?


    Here is a quote:

    "Growing evidence suggests that inflammatory factors play a crucial role in the development of cardiovascular disease and renal injury in hypertensive subjects".
    1





    Mate.







    Ref
    1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2867410/


    Yes it is peer reviewed.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.0¢
Change
0.015(6.67%)
Mkt cap ! $83.98M
Open High Low Value Volume
22.5¢ 24.0¢ 22.5¢ $173.6K 743.6K

Buyers (Bids)

No. Vol. Price($)
8 99346 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 131244 5
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.